Johnson & Johnson MedTech has launched its Kincise 2 surgical automated system, a next-gen automated power tool for primary and revision hip, and revision knee replacement procedures.

The Kincise 2 automated surgical impactor was engineered to boost surgical efficiency, provide control, and reduce physical burden on surgeons compared to manual impaction, the company said. The system was designed to address the repetitive, high-force tasks like repeated mallet strokes that can cause surgeons musculoskeletal pain related to their work.

New design features include reversed energy and push to lock adaptors. A new Acetabular Cup Extraction feature makes Kincise 2 the first, only automated impactor approved to remove well-fixed acetabular components. This broadens its role in complex hip revision and complements its compatibility with advanced techniques like Anterior Approach.

“When I think about what the KINCISE 2 System means for the future of orthopedic care, it’s simple: it helps surgeons stay at their best, longer,” said Dr. Vasilios Mathews, MD, Texas Orthopedic Hospital. “This system is designed to reduce strain and support surgical precision, which means we can focus more fully on the patient in front of us. That’s the true value—technology that not only improves surgical experience but helps us deliver better outcomes for every patient we treat.”

Kincise 2 is now commercially available in the U.S.

“The KINCISE 2 System exemplifies the needs-based innovation we’re bringing to Orthopaedics this year,” said Aldo Denti, Company Group Chairman, Orthopaedics, Johnson & Johnson MedTech. “As more patients undergo joint replacements earlier in life, the demand for revision surgeries is rising. The KINCISE System has demonstrated the ability to help surgeons manage those complex cases by reducing operating time and providing procedural control—ultimately supporting better outcomes for patients.”